Human monoclonal antibody avelumab directly affects the relationship between PD-1 and PD-L1 against PD-L1 and spreads of tumor cells via antibody-dependent cell-mediated cytotoxicity (158). The gene discussed is PDCD1; the disease is neoplasm.